1-9 of 9
Fabian Sanabria
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Parameters, Anemia, and Spleen Response in Patients with MF-Related Anemia Treated with Luspatercept: Efficacy Sub-Analysis from the ACE-536-MF-001 Study

Aaron T. Gerds, Claire N Harrison, Jean-Jacques Kiladjian, Ruben Mesa, Rami S. Komrokji, Prithviraj Bose, Fabian Sanabria, Niloufar Marsousi, Yinzhi Lai, Francesco Passamonti
Journal: Blood
Blood (2023) 142 (Supplement 1): 4565.
https://doi.org/10.1182/blood-2023-178536
Published: 2023
Journal Articles

Predictive Biomarkers of Response to Luspatercept in Patients with Myelofibrosis- (MF) Associated Anemia: Biomarker Analysis from the ACE-536-MF-001 Study

Danny Jeyaraju, Sheida Hayati, Niloufar Marsousi, Aaron T. Gerds, Francesco Passamonti, Fabian Sanabria, Sadanand Vodala, Anita K. Gandhi, Rajasekhar N.V.S. Suragani
Journal: Blood
Blood (2023) 142 (Supplement 1): 6330.
https://doi.org/10.1182/blood-2023-182155
Published: 2023
Journal Articles

Longitudinal Safety of Luspatercept in the Treatment of Anemia in Patients with Myelofibrosis: Results from the ACE-536-MF-001 Study

Rami S. Komrokji, Aaron T. Gerds, Claire N Harrison, Jean-Jacques Kiladjian, Ruben Mesa, Prithviraj Bose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Francesco Passamonti
Journal: Blood
Blood (2023) 142 (Supplement 1): 1820.
https://doi.org/10.1182/blood-2023-174453
Published: 2023
Journal Articles

Characterizing Mild and Moderate Hemophilia A Patients in the Real World: A Patient-Centric Approach

Michelle Witkop, Tao Xu, Gillian Hanson, Richard Ofori-Asenso, Richard H. Ko, Emily Cibelli, Martynas Aizenas, Mark W Skinner, Fabian Sanabria, Amy D. Shapiro
Journal: Blood
Blood (2021) 138 (Supplement 1): 2107.
https://doi.org/10.1182/blood-2021-146543
Published: 2021
Journal Articles

Emicizumab Prophylaxis in Persons with Hemophilia A, Aged ≥50 Years, with Comorbidities - Pooled Data from Four Phase III Studies (HAVEN 1, 3, and 4, and STASEY)

Víctor Jiménez-Yuste, Johannes Oldenburg, Eunice Tzeng, Ben Trzaskoma, Fabian Sanabria, Johnny Mahlangu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2103.
https://doi.org/10.1182/blood-2021-145703
Published: 2021
Journal Articles

Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A with FVIII Inhibitors: Final Analysis

Giancarlo Castaman, Jerzy Windyga, Hazza Alzahrani, Susan Robson, Fabian Sanabria, Monet Howard, Víctor Jiménez-Yuste
Journal: Blood
Blood (2021) 138 (Supplement 1): 344.
https://doi.org/10.1182/blood-2021-145890
Published: 2021
Journal Articles

Emicizumab Outcomes in Hemophilia A Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry

Man-Chiu Poon, Adrienne Lee, Federico Germini, Arun Keepanasseril, Quazi Ibrahim, Francis Nissen, Fabian Sanabria, Michelle Santos, Emma Iserman, Davide Matino, Alfonso Iorio
Journal: Blood
Blood (2021) 138 (Supplement 1): 347.
https://doi.org/10.1182/blood-2021-147195
Published: 2021
Journal Articles

Evaluation of the Safety of Emicizumab Prophylaxis in Persons with Hemophilia A: An Updated Summary of Thrombotic Events and Thrombotic Microangiopathies

Monet Howard, Derrick McKinley, Fabian Sanabria, Richard H. Ko, Francis Nissen
Journal: Blood
Blood (2021) 138 (Supplement 1): 3186.
https://doi.org/10.1182/blood-2021-146147
Published: 2021
Journal Articles

A Novel Methodology for Building Longitudinal, Patient-Centric Real World Datasets in Hemophilia A

Mark W Skinner, Gillian Hanson, Tao Xu, Richard Ofori-Asenso, Richard H. Ko, Emily Cibelli, Francis Nissen, Michelle Witkop, Fabian Sanabria, Amy D. Shapiro
Journal: Blood
Blood (2021) 138 (Supplement 1): 594.
https://doi.org/10.1182/blood-2021-146160
Published: 2021